EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7

Matthias D Kroesen, Lea Wagmann, Anna-Lena Gehl, Alexandra K Kiemer, Markus R Meyer iD

Archives of Toxicology · 2026-09 · 100 (9) · 3977-3988

DOI: 10.1007/s00204-026-04444-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 20.05.2026. Verfasst von Matthias D Kroesen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Homburg, G…. Hauptthemen laut MEDLINE: Xenobiotics, Cell Culture Techniques, Culture Media, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität des Saarlandes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoma cell lines are established in vitro models for xenobiotic metabolism, yet their enzymatic capacity is typically lower than that of primary human hepatocytes. Although widely used as standard culture supplement, fetal bovine serum (FBS) poses ethical concerns and may not provide the optimal nutritional environment for human-specific metabolic functions. This study compared the metabolic activity of the hepatoma cell lines HepG2 and Huh7 cultured in medium supplemented with either human serum (HS) or FBS. Metabolic performance was tested using a dual cytochrome P450 (CYP) substrate cocktail in HepG2, with results compared to literature data for Huh7. For comprehensive evaluation of metabolic capacity, both cell lines were exposed to six synthetic cathinones: 4MeO-αP-VP (4′-methoxy-α-pyrrolidinovalerophenone), 4MeO-αP-BP (4′-methoxy-α-pyrrolidinobutyrophenone), 4MeO-NE-BP (4′-methoxy- N -ethylbutyrophenone), 4MeS-αMor-PrP (4′-methylthio-2-morpholinopropiophenone), 4MeS-αP-BP (4′-methylthio-α-pyrrolidinobutyrophenone), and 4MeS-NE-BP (4′-methylthio- N -ethylbutyrophenone) under both supplement conditions. HepG2 showed unchanged CYP2D6 activity and increased CYP3A4 activity following HS incubation. HS further led to a general increase in metabolite abundance across both cell lines. Particularly the N -oxide formation consistently increased for every compound tested and abundance of most hydroxy and oxo metabolites was higher, most likely due to elevated CYP3A4 activity. Compared to FBS, metabolite formation in the HS group increased significantly, up to fourfold in 12 of 13 reactions for HepG2, and up to fivefold in 8 of 11 reactions for Huh7. Although HepG2 is a more common hepatoma cell line in metabolic research, Huh7 demonstrated higher normalized metabolite formation for most reactions, suggesting it as preferred or highly complementary model. Supplementing culture media with HS significantly enhanced the metabolic competence of the tested hepatoma cell lines. HS can be recommended as a cost-efficient, ethically sound, and physiologically relevant alternative for improving in vitro metabolism assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XenobioticsCell Culture TechniquesCulture MediaCarcinoma, HepatocellularLiver NeoplasmsSerumHumansHep G2 CellsCytochrome P-450 Enzyme SystemCell Line, TumorHepatocytesAnimalsAlkaloidsSynthetic Cathinone

Stichwörter der Autor:innen

Cytochrome P450HepG2Huh7Human serum supplementationSynthetic cathinonesXenobiotic metabolism

Substanzen

XenobioticsCulture MediaCytochrome P-450 Enzyme SystemAlkaloidsSynthetic Cathinonecathinone

Autor:innen und Institutionen

  • Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Homburg, Germany.
  • Department of Pharmacy, Pharmaceutical Biology, Center for Gender-Specific Biology and Medicine (CGBM), PharmaScienceHub (PSH), Saarland University, Saarbrücken, Germany.
  • Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Homburg, Germany. markus.meyer@uni-saarland.de.

ORCID-Profile: Markus R Meyer

Förderung

  • Universität des Saarlandes

Zitieren

APA

Kroesen, M. D., Wagmann, L., Gehl, A. L., Kiemer, A. K., & Meyer, M. R. (2026). Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7. Archives of Toxicology, 100(9), 3977-3988. https://doi.org/10.1007/s00204-026-04444-6

Vancouver

Kroesen MD, Wagmann L, Gehl AL, Kiemer AK, Meyer MR. Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7. Archives of Toxicology. 2026;100(9):3977-3988. doi:10.1007/s00204-026-04444-6

BibTeX
@article{Kroesen2026,
  author = {Kroesen, Matthias D and Wagmann, Lea and Gehl, Anna-Lena and Kiemer, Alexandra K and Meyer, Markus R},
  title = {Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7},
  journal = {Archives of Toxicology},
  year = {2026},
  volume = {100},
  number = {9},
  pages = {3977--3988},
  doi = {10.1007/s00204-026-04444-6}
}
Kostenlos starten →